150
Participants
Start Date
June 10, 2024
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2028
Immune Globulin Infusion (Human), 10% Solution
Given IV
Anti-CD19 CAR T Cells Preparation
Given CAR-T treatment
Saline
Given IV
Biospecimen Collection
Undergo blood sample collection
Survey Administration
Ancillary studies
Electronic Health Record Review
Ancillary studies
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
City of Hope Cancer Center, Duarte
RECRUITING
Fred Hutch/University of Washington Cancer Consortium, Seattle
RECRUITING
Massachusetts General Hospital Cancer Center, Boston
Collaborators (1)
Takeda
INDUSTRY
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER